One of Sri Lanka's fastest growing conglomerates, Hemas Holdings PLC touches the Lives of millions of loyal customers, every day, via its renowned wellness, leisure and mobility services. Over a span of nearly seven decades, Hemas has delivered an award winning range of diversified products and services including high quality home and personal care products that continue to help enrich lives, empower businesses, and make a positive contribution to the nation's economic development
To passionately deliver outstanding products and services, thereby enriching the lives of our customers and creating superior value to our shareholders.
To be the best at Enriching Lives.
Hemas reveres its moral compass: its values.
It is our values that hold us together in meeting success, in providing our customers with quality products and services that they deserve.
Domestic home and personal care manufacturer Value-added hair oil brand in Bangladesh Maritime House representing 4th largest caller at Port of Colombo
Private sector healthcare player Private pharmaceutical manufacturing company
Leisure, Travel and Aviation spectrum
Mr. Husein Esufally started his career with the Group's FMCG (Fast Moving Consumer Goods) business, where he steered the Company for a period of 19 years, during which, the business established a strong consumer franchise. Thereafter, he served for 13 years as the Chief Executive Officer of the Hemas Group until he relinquished his position in March 2014. Presently, he serves as the Non-Executive Chairman of Hemas Holdings PLC, whilst also chairing the Boards of its FMCG and pharmaceutical manufacturing subsidiaries. Mr. Esufally is presently the Non-Executive Chairman of Janashakthi Insurance PLC. He also serves on the Boards of several other companies and is involved in several social projects. Mr. Esufally holds a Bachelor of Science (Honours) Degree in Electronics from the University of Sussex, UK having received his primary education at St. Thomas College, Mt Lavinia.
Mr. Steven Enderby joined Hemas in March 2013 to head the Group's efforts in Mergers and Acquisitions. He took up the Office of Deputy CEO and Director of Hemas Holdings PLC in November 2013 and was appointed the Chief Executive Officer of the Company on 01st April 2014. Mr. Enderby has had a successful track record in the private equity space with Actis, a leading global emerging markets fund, until his retirement in 2011 as an Actis Partner. Some of the most successful private equity transactions he led include South Asia Gateway Terminal. Ceylon Oxygen and Millennium Information Technologies. He has also served on the Boards of leading companies in Sri Lanka and India such as John Keells Holdings, Lion Brewery and Punjab Tractors. He is a Fellow of the Chartered Institute of Management Accountants, and holds a Degree in Economics and Accounting from Queens University Belfast, and a Master's Degree in Development Studies from the University of Melbourne.
With over 35 years' experience in the Tourism industry, Mr. Abbas Esufally has played a pivotal role in expanding the Group's Leisure interest, He serves as a Group Director of Hemas Holdings PLC, Chairman of Serendib Hotels PLC, Dolphin Hotels PLC, Hotel Sigiriya PLC as well as Diethelm Travel Sri Lanka (Pvt) Ltd, Sri Lanka's premier Destination Management Company. He also serves on several other listed and unlisted company boards. He has played an active part in the growth and development of the country's Tourism industry. Mr. Esufally serves as the Chairman of the Mercantile Service Provident Society of the Ceylon Chamber of Commerce and is a Member of the Advisory Committee of the Tourist Hotels Association of Sri Lanka and a Member of the Advisory Council appointed by the Hon. Minister of Tourism. Mr. Esufally is a Fellow Member of both the Institute of Chartered Accountants of England & Wales and the Institute of Chartered Accountants of Sri Lanka. He is an all Island Justice of Peace and serves as the Honorary Consul of Bhutan in Sri Lanka.
Mr. Murtaza Esufally counts more than 25 years of experience in senior management levels. He is the Chairman of Hemas Hospitals (Pvt) Ltd and Hemas Pharmaceuticals (Pvt) Ltd, and is the Non-Executive Chairman of the Centre for Poverty Analysis. He holds a Master's Degree in Business Administration from the Melbourne Business School of the University of Melbourne, He is a Barrister of the Lincoln's Inn and holds a Bachelor of Law Degree from the University of Essex, UK. Mr. Esufally is an Attorney-at-Law of the Supreme Court of Sri Lanka.
Mr. Imtiaz Esufally serves as the Chairman of the Transportation Sector of the Group and serves as a Member of the Hemas Audit Committee. He served as the Chairman of Hemas Power PLC until its disposal in 2014. Mr. Esufally holds a Bachelor of Arts (Honours) Degree in Accounting and Economics from the University of Kent, UK. He counts over 25 years of management experience and has been in the forefront of the Transportation industry in Sri Lanka.
Mr. Malinga Arsakularatne was appointed as the Managing Director of the Group's newly formed Leisure, Travel and Aviation Group. Prior to this appointment Mr. Arsakularatne served as the Chief Financial Officer of the Company for over 8 years. Mr. Arsakularatne has 19 years of experience in investment management, corporate finance and business strategy. He also serves on the Board of Serendib Hotels PLC. Mr. Arsakularatne also holds directorships in other unlisted subsidiary companies within the Hemas Group and also serves as a Non-Executive Director of NDB Capital Holdings PLC and SUIT. Mr. Arsakularatne is a CFA Charter Holder and a Past President of CFA Sri Lanka. He is also a Fellow Member of the Chartered Institute of Management Accountants (CIMA), UK and a Past Board Member of the CIMA Sri Lanka Division. He holds a BSc in Computer Science & Engineering from the University of Moratuwa, an MSc in Investment Management from Cass Business School, and an Executive MBA from INSEAD. Mr. Arsakularatne is also a Member of the Board of Management of the Group.
Mr. Ramabadran Gopalakrishnan has over 48 years of experience in professional management with 31 years in Unilever and 17 years in TATA. He has served as Chairman of Unilever Arabia, as Managing Director of Brooke Bond Lipton India, and as Vice Chairman of Hindustan Unilever Limited, After his Unilever career, he joined Tata Sons as a Director. He retired from TATA in December 2015 and currently serves as an Independent Director on the boards of the Indian subsidiaries of Akzo Nobel and Castrol India, Mr. Gopatakrishnan studied physics at Calcutta University. Engineering at IIT Kharagpur and completed an Advanced Management Program at the Harvard Business School. He is a Past President of the All India Management Association.
Dr. Anura Ekanayake is a former Chairman of the Ceylon Chamber of Commerce, the Industrial Association of Sri Lanka and The International Natural Rubber Council. He has had an illustrious career in public service serving as a Senior Economist of the Mahaweli Authority, Director on the Boards of the State Plantations Corporation and JEDB, Director of Planning to the Ministry of Plantation Industries and Director General of the Ministry of Public Administration. Dr. Ekanayake held directorships in all 23 regional plantations companies and also served on the Tea Research Board, Postgraduate Institute of Agriculture and Plantation Housing and Social Welfare Development Trust. He Left his two decade Long public service and joined Unilever Sri Lanka and served as Director - Human Resources and Corporate Relations for 8 years. He serves at present on a number of boards of listed companies and non-Listed companies. Dr. Ekanayake, holds a B.A. (Horns) and MSc (Agriculture) from the University of Peradeniya and a Ph.D in Economics from the Australian National University. He is also a Fellow Member of the Institute of Certified Professional Managers. Dr. Ekanayake is a firm advocate of developing human capital and people transformation.
Mr. Saktha Amaratunga joined the Board in January 2016. Mr. Amaratunga is currently a Commissioner of PT Agro Indomas Indonesia and is also a Member of the Upstream and Downstream Audit Sub Committee of Goodhope Asia Holdings Ltd a subsidiary of the Carson Cumberbatch Group. He was previously Regional Audit Controller (Asia Pacific) for British American Tobacco. He has more than 20 years' experience with British American Tobacco. having performed senior finance roles for the Group in Sri Lanka and the United Kingdom. and also being the Finance Director of British American Tobacco operations in the Czech Republic, Sri Lanka, Switzerland, Japan and Malaysia (IT Shared Services Organisation). He has many years of experience in Strategy Development, Business Restructuring, Risk and Governance, International Finance and People Development. He is a Fellow Member of the Chartered Accountants of Sri Lanka, Associate Member of the Chartered Institute of Management Accountants, UK and also a Member of CPA Australia.
Mr Jyotindra Trivedi has more than 35 years of experience in Indian financial services industry and more than 25 years with Indian Venture Capital and Private Equity Industry. Mr Trivedi joined CDC, a UK based development finance institution, in 1997 to set up its Mumbai office. He was one the founding partners when Actis LLP was spun out of CDC in 2004. He took over Leadership of Actis South Asia in 2007. Mr Trivedi retired from Actis in 2017. By 2017. Actis had raised more than US$12bn since it was formed in 2004. As a member of global. investment committee of Actis Mr Trivedi had an overview of the investment activity of Actis across its key markets such as China, South Asia, Africa and Latin America and its key sectors such as Consumer, Healthcare, FinanciaL Services and Industrial. Mr Trivedi has been involved in numerous investments of Actis in India, most notabLy India Infoline(IIFL), Glenmark Pharmaceuticals, UTI Bank(now Axis Bank), Sterling Hospitals, Paras Pharmaceuticals and Avtec many of which have grown into Large businesses with leadership position in their respective sectors. Prior to Joining CDC, Mr Trivedi was senior vice president of GVFL, one of the first VC funds India. Mr Trivedi was part of the founding team of GVFL when it was set up in 1990 and was involved with its first three funds which focused on technology based start-up and early stage companies. Prior to joining GVFL he worked with GIIC, a development bank and AtuL Products, a dyes and intermediates conglomerate. Mr Trivedi graduated as a chemical engineer from the Indian Institute of Technology, Bombay and holds a Diploma in Finance from the Institute of Chartered Financial Analysts of India. Mr Trivedi currently serves on the board of Ostro Energy Private Limited which is an Actis owned company and is building a clean energy platform with Wind and Solar assets of more than 1000mw capacity in India.
Prof de Silva had her primary and secondary education at CMS Ladies College, Colombo. She graduated MBBS from the University of Colombo in 1986 and went on to obtain a Masters in Medical Parasitology from the London School of Hygiene and Tropical Medicine, UK and MD and Board Certification in Medical Parasitology, from Colombo University’s Postgraduate Institute of Medicine. She was a Commonwealth Fellow at the University of Oxford, UK in 1995/96, and a FAIMER Fellow at the George Washington University School of Medicine in Washington DC, USA, in 2004/05. She is an expert advisor on Neglected Tropical Diseases to the World Health Organization, serving both WHO Headquarters and the South East Asia Regional Office in many different capacities since 2000. Following an enriching career in the medical industry, Prof de Silva was appointed as the Dean of the Faculty of Medicine, University of Kelaniya from 2012 to 2018. At present she serves as the Chairman of the Board of Trustees of the Ayati Trust Sri Lanka, a collaborative partnership between the University of Kelaniya and multiple corporates in Sri Lanka, which aims to establish a national centre of excellence to serve children with disabilities.
He joined Hemas FMCG in 1997 and was involved in Sales and Brand Management until 2006. He joined Hemtours in 2006 and subsequently was part of the team launching Diethelm Travel in Sri Lanka and Maldives. Harith is currently the President of Sri Lanka Association of Inbound Tour Operators (SLAITO) and also a Board member of the Sri Lanka Tourism Promotions Bureau (SLTPB). He is a Member of the Chartered Institute of Marketing (CIM), UK and has an MBA from the University of Southern Queensland, Australia.
Kasturi is the Managing Director of Hemas Pharmaceuticals and the Group’s Logistics and Maritime sectors. She is a Fellow of the Chartered Institute of Management Accountants, UK and has served as Board Member of CIMA, Sri Lanka. She counts for over 29 years of managerial experience in multiple industries and functions spanning from auditing, consulting, logistics, leisure and travel and pharmaceuticals. Kasturi joined Hemas in 2002 as the Finance Director of Hemtours (Presently, Diethelm Travel) and in 2005 she was appointed the Head of Shared Services for the Group and subsequently as the Chief Process Officer of the Group in 2007. In 2011 she was appointed as the Managing Director of the Transportation Sector and in 2016, Managing Director of the Pharmaceutical Distribution Business. In 2017 she was appointed a Non-Independent Non-Executive Director of Morison PLC and in 2018 as a Non-Executive of Capital Alliance Ltd. Kasturi is also a member of the Economic Policy Committee of the Ceylon Chamber of Commerce.
Roy is the Managing Director of Hemas Manufacturing (Pvt) Ltd. He is a Fellow of the Chartered Institute of Management Accountants of UK, a Fellow of the Institute of Certified Management Accountants of Sri Lanka and he holds a Postgraduate Diploma in Finance & Business Administration from the Institute of Chartered Accountants. He counts over 20 years of management experience in the fields of Finance, IT, Supply Chain, Channels/Customer Development and General Management. He has held key positions in several FMCG, Plantations, Construction and Logistics companies.
As the Chief Digital Officer at Hemas Holdings PLC., Chandima Leads Information Technology, Digital and Innovation teams to help businesses within Hemas embrace more profitable and growth oriented business models and to deliver a great customer experience across all products/service touch points. Chandima has accumulated over 20 years of experience in applying Information Technology across multiple industries improving business performance. Prior to joining Hemas, Chandima was with MAS Holdings, Sri Lanka for fourteen years, lastly as the CEO for Sabre Technologies a fully owned subsidiary of MAS servicing technology startups in USA. Chandima started his career at Unilever as a management trainee and Later was involved in a global project for Unilever tea business. Chandima has a degree in Information Systems from Manchester Metropolitan University, UK and has followed strategic management courses from renowned business schools Ashridge, Henley, INSEAD and Kellogg's.
Dimuth functions as the Group Human Resource Director. He joined Hemas FMCG in 1999 and worked as the Head of Human Resources from 2006 to 2008. He joined Hemas Hospitals as the Head of Human Resources in 2008 and was subsequently promoted to the Head of Group Human Resources in 2010 and in 2011 to the role of Director. Dimuth holds a Degree in Commerce and Management (specialized in International Trade) from the University of Sri Jayewardenepura and a National Diploma in Human Resources Management from the Institute of Personnel Management. He is also a Member of the Association of Human Resources Professionals, Sri Lanka.
Himesh joined Hemas in 2014 to lead Strategic Innovation for growth of the organization. Prior to joining Hemas. Himesh has worked in the Biotechnology industry in Oxford UK, and at the Sri Lanka Institute of Nanotechnology (SLINTEC) in both Business Development and Scientific Research. He obtained his Doctorate from the University of Cambridge in the field of cancer research and has a BSc Honours from the University of Colombo in Molecular Biology and Biochemistry. He holds an MBA from the Postgraduate Institute of Management. University of Sri Jayewardenepura. He is also a Member of the Chartered Institute of Marketing, UK.
Lakith joined Hemas on 01st April 201.5. He is a well-known leader in the Healthcare industry having been the CEO of one of the most successful city hospitals over the past 7 years. He has over 20 years' experience in top management at a host of healthcare related MNCs including BiBraun Asia Pacific, Lifesery and ConvaTec A Bristol Myers Squibb Company of USA amongst others. He holds a Doctorate in Business & Management, an MBA from University of Western Sydney, Australia, and is a Certified Professional Marketer from the Asia Pacific Marketing Federation and holds a Postgraduate DipLoma in Marketing from the Sri Lanka Institute of Marketing. Lakith has memberships in several professionaL Associations and Federations. He is a Member of the Private Health Services Regulatory Council of the Ministry of Health and also serves the Regulatory CounciL in various sub-committees.
Rakesh is the Managing Director – Sri Lanka of Hemas Manufacturing (Pvt) Ltd. and counts over 20 years of work experience in Consumer Marketing & Sales management. He joined Hemas Manufacturing (Pvt) Ltd. in 2012 as Director - Marketing and has recently been elevated to the post of Managing Director – Sri Lanka. Prior to joining Hemas, Rakesh spent 15 years with Colgate Palmolive (India) Ltd. in roles of increasing responsibility in Consumer Marketing & Sales. During this period he has had several stints in Brand, Sales & Category Management and Market Development. In addition, he has also been a certified Category Management Trainer and Global Ethics & Compliance Investigator. Amongst several national awards at Colgate he is also a recipient of Colgate Palmolive’s highest Global Annual Award : The 2011 Global Chairman’s “You Can Make A Difference Award”. Rakesh holds a Bachelor of Commerce (B.Com) from Calcutta University – India, an International Diploma in Accounting Studies from Oxford Brookes University, Oxford, UK and a Bachelor of Business (Accounting) and MBA from the Royal Melbourne Institute of Technology (RMIT), Melbourne, Australia.
Prior to her role in Hemas, Ruwani was the CEO and Founder of Vox & Co. a boutique strategy consultancy firm and was Head of Research & Consulting at Stax, a U.S. based strategy consulting firm for 6 years. Ruwani is on the board of two of Hemas Digital Healthcare startups. She previously served on the board of Colombo Academy of Hospitality Management at SLIIT. Ruwani has an MA in Economics from the University of Edinburgh.
Asitha Samaraweera currently is the Managing Director of Atlas Axillia Co Ltd., a Hemas Holdings group company. Atlas Axillia Co Ltd is one of Sri Lanka’s most respected local brands and is a market leader in school stationery and notebooks, pens, pencils and colour products, with products retailed in over 70,000 outlets across Sri Lanka.
Before his current role he counts over 12 years’ experience in leading FMCG businesses both in Sri Lanka and overseas. Asitha was the CEO of CBL Cocos (Pvt) Ltd., and CBL Global Foods, both subsidiaries of Ceylon Biscuits Limited before joining Atlas Axilla. The company was a leading player in the coconut products industry with a substantial export interest.
Prior to his role at CBL, Asitha headed IFFCO (Frozen Foods) and GFI – leading Dubai-based FMCG companies for six years. The two companies are leading processed meat and frozen bakery product manufactures in the Middle East.
Prior to his stint in the middle east he served as CEO of Keells Food Products and Vice President at John Keells Holdings PLC. Keells food Products PLC is the leading processed food manufacturer and marketer in Sri Lanka.
Asitha began his career with Nestle joining as a management training and rising in the ranks in the marketing arena. In his career in marketing he was involved in many successful campaigns which included the Nestomalt’s defeat of Powermalt which is now a well know case study.
He has a background in Marketing with an MSc in International Accounting and Finance, London School of Economics one of the leading universities in the world. He also has a BSc in Business Administration, Washington University, St Louis, MO, USA. His Schooling was at St Thomas College, Mount Lavinia.
Mr. Zalmi Fazeel has served as an Executive Vice President heading the finance, legal and IT operations of Saudi Cable Company, Saudi Arabia between 2013 and 2017. He served at the Savola Group, Saudi Arabia, between 2000 and 2013 in various roles, including that of Executive Director-Group Treasury, Chief Financial Officer of Edible Oil Subsidiaries, Head of Finance and IT at the United Sugar Company, and Head of Finance Shared Services. He started his career at Pfizer Sri Lanka currently known as Astron Limited, in 1984. He was appointed to the Board of Astron in 1992, which position he held until he moved to Saudi Arabia in January 2000. He was an independent Board member and Chaired the Audit committee of Hemas Hospitals (Pvt) Limited, from March 2017 to July 2018. At present he serves the Board of Hemas Hospitals (Pvt) Ltd as a Non- Executive Director. He is a Fellow of the Chartered Institute of Management Accountants (UK). Mr. Zalmi Fazeel has been appointed as the Group Chief Financial Officer of Hemas Holdings PLC w.e.f 1st September 2018.
Mr. Zalmi Fazeel has been appointed as the Group Chief Financial Officer of Hemas Holdings PLC w.e.f 1st September 2018.
Riad is the Legal Consultant to Hemas Holdings PLC. He holds a Bachelor's Degree in Law (LLB) from the University of London and a Master of Laws Degree (LL.M) from the University of Colombo. He is a Barrister of the Lincoln's Inn, UK, and an Attorney-at-Law. He has been associated with the Hemas Group for the past 10 years. Riad has been a civil. Law practitioner for the past 18 years.